These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 33808714)

  • 1. Therapeutic Applications of Botulinum Neurotoxin for Autonomic Symptoms in Parkinson's Disease: An Updated Review.
    Mitchell SD; Sidiropoulos C
    Toxins (Basel); 2021 Mar; 13(3):. PubMed ID: 33808714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Botulinum Neurotoxin in Parkinson's Disease: A Critical Appraisal.
    Jost WH
    Toxins (Basel); 2021 Jan; 13(2):. PubMed ID: 33503872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum Toxin Treatment of Autonomic Disorders: Focal Hyperhidrosis and Sialorrhea.
    Hosp C; Naumann MK; Hamm H
    Semin Neurol; 2016 Feb; 36(1):20-8. PubMed ID: 26866492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Management of autonomic dysfunction in Parkinson's disease].
    Crespo-Burillo JA; Alarcia-Alejos R
    Rev Neurol; 2015 Apr; 60(8):355-64. PubMed ID: 25857860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of botulinum toxin in Parkinson's disease.
    Jocson A; Lew M
    Parkinsonism Relat Disord; 2019 Feb; 59():57-64. PubMed ID: 30579818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An update on the use of botulinum toxin therapy in Parkinson's disease.
    Mills R; Bahroo L; Pagan F
    Curr Neurol Neurosci Rep; 2015 Jan; 15(1):511. PubMed ID: 25407133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-motor symptoms in Parkinson's disease.
    Park A; Stacy M
    J Neurol; 2009 Aug; 256 Suppl 3():293-8. PubMed ID: 19711119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Disorders of autonomic regulation in Parkinson syndrome].
    Jost WH
    Fortschr Neurol Psychiatr; 1995 May; 63(5):194-205. PubMed ID: 7782020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing autonomic dysfunction in Parkinson's disease: a review of emerging drugs.
    Kulshreshtha D; Ganguly J; Jog M
    Expert Opin Emerg Drugs; 2020 Mar; 25(1):37-47. PubMed ID: 32067502
    [No Abstract]   [Full Text] [Related]  

  • 10. Sialorrhea in Parkinson's Disease.
    Isaacson J; Patel S; Torres-Yaghi Y; Pagán F
    Toxins (Basel); 2020 Oct; 12(11):. PubMed ID: 33142833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease-oriented approach to botulinum toxin use.
    Jankovic J
    Toxicon; 2009 Oct; 54(5):614-23. PubMed ID: 19073203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum Toxin Therapy for Nonmotor Aspects of Parkinson's Disease.
    Sławek J; Madaliński M
    Int Rev Neurobiol; 2017; 134():1111-1142. PubMed ID: 28805566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin type A and type B for sialorrhoea in Parkinson's disease: a case for switching therapy?
    Santamato A; Panza F; Solfrizzi V; Frisardi V; Ranieri M; Fiore P
    J Rehabil Med; 2008 Nov; 40(10):882-3. PubMed ID: 19242630
    [No Abstract]   [Full Text] [Related]  

  • 14. Botulinum toxin in the treatment of tremors, dystonias, sialorrhea and other symptoms associated with Parkinson's disease.
    Sheffield JK; Jankovic J
    Expert Rev Neurother; 2007 Jun; 7(6):637-47. PubMed ID: 17563247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recognition and treatment of autonomic disturbances in Parkinson's disease.
    Li K; Reichmann H; Ziemssen T
    Expert Rev Neurother; 2015 Oct; 15(10):1189-203. PubMed ID: 26416396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From Toxin to Treatment: A Narrative Review on the Use of Botulinum Toxin for Autonomic Dysfunction.
    Rempel L; Malik RN; Shackleton C; Calderón-Juárez M; Sachdeva R; Krassioukov AV
    Toxins (Basel); 2024 Feb; 16(2):. PubMed ID: 38393175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sialorrhea in patients with Parkinson's disease: safety and administration of botulinum neurotoxin.
    Egevad G; Petkova VY; Vilholm OJ
    J Parkinsons Dis; 2014; 4(3):321-6. PubMed ID: 24919823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum Toxin Therapy for Parkinson's Disease.
    Wagle Shukla A; Malaty IA
    Semin Neurol; 2017 Apr; 37(2):193-204. PubMed ID: 28511260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. State-of-the-art pharmacotherapy for autonomic dysfunction in Parkinson's disease.
    Quarracino C; Otero-Losada M; Capani F; Pérez-Lloret S
    Expert Opin Pharmacother; 2020 Mar; 21(4):445-457. PubMed ID: 31957505
    [No Abstract]   [Full Text] [Related]  

  • 20. The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease.
    Seppi K; Weintraub D; Coelho M; Perez-Lloret S; Fox SH; Katzenschlager R; Hametner EM; Poewe W; Rascol O; Goetz CG; Sampaio C
    Mov Disord; 2011 Oct; 26 Suppl 3(0 3):S42-80. PubMed ID: 22021174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.